DPNP(diabetic peripheral neuropathy pain)
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Patients diagnosed with diabetic peripheral neuropathy undergoing unilateral lumbar sympathetic ganglion destruction; 2. Aged from 18 to 80 years; 3. ASA II or III; 4. BMI 18 ~ 30 kg/m^2.
Exclusion criteria
Exclusion criteria: 1. Severe heart, lung, liver, kidney and other diseases; 2. Severe diabetic complications, such as diabetic renal failure and diabetic heart disease; 3. The skin at the puncture site has ulceration, swelling, inflammation and infection; 4. Patients with abnormal coagulation function; 5. History of internal fixation after lumbar laminectomy or severe anatomic variation, such as scoliosis and tumor; 6. History of lumbar sympathetic neurochemistry or thermal lysis; 7. Pregnancy; 8. Those allergic to local anesthetics, anhydrous alcohol and iodohexyl injection; 9. Patients with mental illness or cognitive dysfunction caused by any reason who cannot cooperate to complete treatment evaluation or sign informed consent; 10. Patients who had received other treatment regimens for lumbar sympathetic ganglia 1 month before the study began.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Performance time;Success rate of damage;Imaging time;Number of needle redirections; | — |
Countries
China
Contacts
Foshan Fosun Chancheng Hospital